Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Arimidex
Active Ingredient(s): Anastrozole 1mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
Product: Flixotide (CFC-Free)
Active Ingredient(s): Fluticasone propionate 125µg/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product: Flixotide (CFC-Free)
Active Ingredient(s): Fluticasone propionate 250µg/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product: Flixotide (CFC-Free)
Active Ingredient(s): Fluticasone propionate 50µg
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product: Flixotide Accuhaler
Active Ingredient(s): Fluticasone propionate 100µg
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product: Flixotide Accuhaler
Active Ingredient(s): Fluticasone propionate 250µg
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product: Flixotide Accuhaler
Active Ingredient(s): Fluticasone propionate 50µg
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product: Flixotide Accuhaler
Active Ingredient(s): Fluticasone propionate 500µg
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product: Flixotide Rotadisk
Active Ingredient(s): Fluticasone propionate 100µg
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Production, Evreux, France
Product: Flixotide Rotadisk
Active Ingredient(s): Fluticasone propionate 250µg
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Production, Evreux, France
Product: Flixotide Rotadisk
Active Ingredient(s): Fluticasone propionate 50µg
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Production, Evreux, France
Product: Flixotide Rotadisk
Active Ingredient(s): Fluticasone propionate 500µg
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Production, Evreux, France
Product: Flixotide
Active Ingredient(s): Fluticasone propionate 25µg/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia
Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France
Dated this 15th day of May 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).